{"nct_id":"NCT01953692","title":"A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2013-11-22","start_date_type":"ACTUAL","primary_completion_date":"2020-06-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}